Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Quanterix Corp
(NQ:
QTRX
)
17.35
-0.53 (-2.96%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Quanterix Corp
< Previous
1
2
3
Next >
UK Dementia Research Institute Biomarker Factory Powers Alzheimer’s Disease Breakthroughs with Quanterix Simoa® Technology
February 07, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix’ Simoa® Technology Powers Latest Breakthrough in Epstein-Barr Virus and Multiple Sclerosis
January 26, 2022
From
Quanterix
Via
Business Wire
Quanterix Provides Operational and Preliminary Financial Highlights
January 13, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix to Present at 40th Annual J.P. Morgan Healthcare Conference
January 06, 2022
From
Quanterix Corporation
Via
Business Wire
Quanterix Recognized as a Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500™
November 17, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix’ Simoa® Technology Powers Advances in Alzheimer’s Disease Research Presented at 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
November 16, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
November 11, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Co-Inventor of Simoa® David Walt Receives Kabiller Prize in Nanoscience and Nanomedicine
November 08, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Corporation Releases Operating Results for Third Quarter of 2021
November 04, 2021
From
Quanterix
Via
Business Wire
Quanterix Corporation to Release Third Quarter 2021 Financial Results on Nov. 4, 2021
October 28, 2021
From
Quanterix
Via
Business Wire
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181 Assay for Alzheimer’s Disease
October 11, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Hosts Webinar with Leading Pathologist from Emory Medical Laboratories
September 20, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test
September 13, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix to Host Webinar with Leading Pathologist from Emory Medical Laboratories: “COVID-19 Testing in a Residential University Setting: Implementation, Insights, and Learnings”
September 10, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Releases Statement
August 27, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix to Participate in the Canaccord Genuity 41st Annual Growth Conference
August 09, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021
August 06, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Corporation Releases Operating Results for Second Quarter of 2021
August 05, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Corporation to Release Second Quarter 2021 Financial Results on Aug. 5, 2021
July 28, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Appoints Michael Doyle as Chief Financial Officer
June 28, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix’ Simoa Technology Powers Largest and Most Diverse Global Investigation of Plasma Neurofilament Light’s Role in Dementia Diagnosis
June 07, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference and Appear on the June 3 Episode of The Bio Report
June 02, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Appoints Masoud Toloue as President of Quanterix and Diagnostics
May 11, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Corporation Releases Operating Results for First Quarter 2021
May 05, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Corporation to Release First Quarter 2021 Financial Results on May 5, 2021
April 28, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Appoints Laurie Olson to Board of Directors
April 28, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Webinar: Recent Advancements in Neurodegenerative Biomarkers: Progress Towards A Diagnostic Blood Test for Alzheimer’s Disease
April 22, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Announces Appointment of Interim Chief Financial Officer
April 21, 2021
From
Quanterix Corporation
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.